Epstein Secrets

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

> " from June 28 and=suggests risk parity fund leverage is high and we do not think the relatio=ships have changed significantly. c=span> Today on Bloomberg: Junk Debt Keeps Climbing Desp=te Plunging Oil Prices After moving in lockstep with oil markets for much o= the last two years, high-yield bonds have gone their own way and pos=e

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

> " from June 28 and=suggests risk parity fund leverage is high and we do not think the relatio=ships have changed significantly. =/span> Today on Bloomberg: Junk Debt Keeps Climbing Desp=te Plunging Oil Prices After moving in lockstep with oil markets for much o= the last two years, high-yield bonds have gone their own way and pos=e

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

arity fund leverage is high and we do not think the relatio=ships have changed significantly. <=span> 14 EFTA_R1_01556382 EFTA02454573 Today on Bloomberg: Junk Debt Keeps Climbing Desp=te Plunging Oil Prices After moving in lockstep with oil markets for much o= the last two years, high-yield bonds have gone their own way and pos=e